These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD? Eiser NM; Phillips C; Wooler PA Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505 [TBL] [Abstract][Full Text] [Related]
3. [A comparison of bronchodilating drugs in the treatment of stable COPD]. Nishimura K; Koyama H; Izumi T Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837 [TBL] [Abstract][Full Text] [Related]
4. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681 [TBL] [Abstract][Full Text] [Related]
5. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease. Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716 [TBL] [Abstract][Full Text] [Related]
6. The role of domiciliary nebulizers in managing patients with severe COPD. Eiser N; Angus K; McHale S Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108 [TBL] [Abstract][Full Text] [Related]
7. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease. Colice GL Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712 [TBL] [Abstract][Full Text] [Related]
8. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study. Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005 [TBL] [Abstract][Full Text] [Related]
9. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Hadcroft J; Calverley PM Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693 [TBL] [Abstract][Full Text] [Related]
10. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328 [TBL] [Abstract][Full Text] [Related]
11. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. Pillet O; Manier G; Castaing Y Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900 [TBL] [Abstract][Full Text] [Related]
12. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease. Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369 [TBL] [Abstract][Full Text] [Related]
13. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
14. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551 [TBL] [Abstract][Full Text] [Related]
15. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640 [TBL] [Abstract][Full Text] [Related]
16. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma]. Dor A; Krasnowska M; MaĆolepszy J Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617 [TBL] [Abstract][Full Text] [Related]
17. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565 [TBL] [Abstract][Full Text] [Related]
18. [Response to inhaled bronchodilators in chronic airway obstruction]. Holten K Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284 [TBL] [Abstract][Full Text] [Related]
19. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. Ikeda A; Nishimura K; Koyama H; Izumi T Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768 [TBL] [Abstract][Full Text] [Related]
20. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease. Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]